Biden Cancer Initiative highlights SEngine.

Biden Cancer Initiative highlights SEngine.

Mentioned is our project Apollo a first of its kind 100-patient clinical trial – using an unbiased, CLIA (Clinical Laboratory Improvement Amendment) certified high-throughput test (P.A.R.I.S®, SEngine Precision Medicine) to identify specific sensitivities in each patient from a large panel of oncology drugs.

A strategy for studying rare cancer phenotypes

A strategy for studying rare cancer phenotypes

The partnership and technologies developed by Cure First, SEngine Precision Medicine, in collaboration with Englander Institute for Precision Medicine at Weill Cornell Medicine, led to a seminal study in prostate cancer. Personalized cancer models from patients were developed and novel therapeutic combinations discovered and validated.

Mendelspod Podcast

Mendelspod Podcast

Seattle Startup Takes Precision Oncology to the Next Step: Carla Grandori, CEO, SEngine

AACR - Chicago

AACR - Chicago

SEngine team presenting five posters at American Association for Cancer Research annual conference.

The Society for Functional Precision Medicine

The Society for Functional Precision Medicine

Got f(x)? Join The Society for Functional Precision Medicine (SFPM) and help advance the science and medicine of direct functional testing of patient cancer cells. SFPM's mission is to facilitate implementation of functional assays into clinical care.

SEngine + Fred Hutch

SEngine + Fred Hutch

SEngine Precision Medicine Signs New Licensing Agreement with Fred Hutchinson Cancer Research Center

Cancer Discovery Spotlight

A Road Map for Precision Cancer Medicine Using Personalized Models. Cancer Discovery May 2017 PMID_28461408